Alivus Life Sciences Ltd.

A fair growth of 12.05% in the revenue at Rs. 6418.44 millions was reported in the December 2024 quarter as compared to Rs. 5728.04 millions during year-ago period.A slim rise of 15.32% was recorded in the Net profit for the quarter ended December 2024 to Rs. 1369.60  millions  From Rs. 1187.65 millions.Operating profit for the quarter ended December 2024 rose to 2007.64 millions as compared to 1742.47 millions of corresponding quarter ended December 2023.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202412	202312	% Var	202412	202312	% Var	202403	202303	% Var
Sales	6418.44	5728.04	12.05	17373.39	17466.17	-0.53	22832.14	21612.20	5.64
Other Income	104.56	16.91	518.33	244.82	89.11	174.74	120.42	289.57	-58.41
PBIDT	2007.64	1742.47	15.22	5086.34	5417.12	-6.11	6862.88	6712.50	2.24
Interest	4.58	3.87	18.35	11.54	11.82	-2.37	15.46	5.47	182.63
PBDT	2003.06	1738.60	15.21	5074.80	5405.30	-6.11	6847.42	6707.03	2.09
Depreciation	151.59	131.77	15.04	446.39	389.18	14.70	534.52	420.94	26.98
PBT	1851.47	1606.83	15.23	4628.41	5016.12	-7.73	6312.90	6286.09	0.43
TAX	481.87	419.18	14.96	1190.82	1286.60	-7.44	1604.02	1616.48	-0.77
Deferred Tax	13.81	30.57	-54.82	45.19	75.00	-39.75	81.88	110.37	-25.81
PAT	1369.60	1187.65	15.32	3437.59	3729.52	-7.83	4708.88	4669.61	0.84
Equity	245.07	245.05	0.01	245.07	245.05	0.01	245.05	245.05	0.00
PBIDTM(%)	31.28	30.42	2.82	29.28	31.01	-5.60	30.06	31.06	-3.22